Fox Chase Cancer Center

Articles

Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer

April 4th 2025

Removing and testing more lymph nodes during surgery was associated with more accurate staging and better survival rates for patients with colon cancer.

Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds

April 1st 2025

Results from a study presented by Fox Chase Cancer Center suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.

Fox Chase Cancer Center’s Jaye Gardiner Receives Research Grant From Uplifting Athletes

March 26th 2025

Jaye Gardiner, PhD, postdoctoral fellow at Fox Chase Cancer Center to receive a grant from the nonprofit Uplifting Athletes during its Young Investigators Draft.

Fox Chase Cancer Center’s Biosample Repository Receives Reaccreditation From College of American Pathologists

March 12th 2025

Fox Chase Cancer Center’s Biosample Repository Facility was recently awarded reaccreditation by the College of American Pathologists based on the results of an on-site inspection.

Fox Chase Cancer Center Researchers Review Role of AKT Pathway in Tumors and the Potential to Block it to Fight Cancer

March 7th 2025

Researchers at Fox Chase Cancer Center published 2 reviews on the role of AKT, also known as protein kinase B, in the development and treatment of cancer.

Fox Chase Cancer Center, Temple Health Study Reveals Timely Treatment Is Critical for Rectal Cancer Survival

February 28th 2025

Starting treatment within 60 days of initial evaluation significantly improves survival rates for patients with rectal cancer.

Some Patients With Kidney Cancer Can Stop Combination Treatment After Two Years, Fox Chase Cancer Center Study Finds

February 18th 2025

Some patients with metastatic kidney cancer achieving a good response to a combination therapy can safely stop or pause treatment after 2 years.

Fox Chase Cancer Center Welcomes Dr Michael Noonan

February 14th 2025

Fox Chase Cancer Center announced the hiring of Michael Noonan, DO, MS, as an Assistant Professor in the Supportive Oncology and Palliative Care Program.

Fox Chase Cancer Center Researchers Review Guidelines for Therapies Given to Melanoma Patients Before and After Initial Treatment

February 11th 2025

A team of colleagues at Fox Chase Cancer Center recently published an updated review of guidelines governing the use of neoadjuvant and adjuvant therapy for patients with melanoma.

Fox Chase Cancer Center’s Dr. Eric Goodlev Named a Fellow of the American Academy of Hospice and Palliative Medicine

February 4th 2025

Eric Goodlev, MD, associate professor in the supportive oncology and palliative care program, was recently named a Fellow of the American Academy of Hospice and Palliative Medicine.

Fox Chase Cancer Center’s Austin Williams Named 2025 Society of Surgical Oncology Presidential Scholar

February 3rd 2025

Austin D. Williams, MD, MSEd, FACS, was recently named a Presidential Scholar by the Society of Surgical Oncology.

Fox Chase Cancer Center Researchers Present Data on Use of Checkpoint Inhibitors and Test Measuring Their Benefit to Patients

January 30th 2025

The number of patients receiving immune checkpoint inhibitors and PD-L1 testing for treatment of gastroesophageal cancer increased following FDA approval.

Fox Chase Cancer Center Welcomes Weiran Feng, PhD

January 27th 2025

Weiran Feng, PhD, Assistant Professor in the Nuclear Dynamics and Cancer Research Program and a member of the Cancer Epigenetics Institute (CEI).

Fox Chase Cancer Center Scientist Yash Chhabra Honored With NextGen Stars Award From American Association for Cancer Research

January 23rd 2025

Yash Chhabra, PhD, Assistant Professor in the Cancer Signaling and Microenvironment Research Program, was recently honored with the American Association for Cancer Research’s NextGen Stars Award.

Fox Chase Cancer Center’s Roland Dunbrack Appointed Co-Leader of the Cancer Signaling and Microenvironment Program

January 21st 2025

Roland Dunbrack, PhD, of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was appointed co-leader of the program.

Fox Chase Cancer Center Welcomes Dr. Qing Chen

January 17th 2025

Qing Chen, MD, PhD, has joined as a new assistant professor in the Cancer Signaling and Microenvironment Research Program.

New Protocol Reduces Adverse Effects In Use of Key Drug for Multiple Myeloma

December 19th 2024

Fox Chase Cancer Center researchers have identified a pretreatment protocol that reduces adverse effects for the drug motixafortide.

Fox Chase Cancer Center’s Department of Clinical Genetics Expands Reach With Genetic Counseling and High-Risk Clinical Services at Chestnut Hill Hospital

December 6th 2024

Fox Chase Cancer Center is offering genetic counseling for those considered at high risk for breast cancer at Temple Health - Chestnut Hill Hospital.

Fox Chase Cancer Center’s Dr. Anthony M. Villano and Dr. Austin D. Williams Named Fellows of the American College of Surgeons

December 4th 2024

Fox Chase Cancer Center’s Anthony M. Villano, MD, FACS, and Austin D. Williams, MD, MSED, FACS, were named Fellows of the American College of Surgeons.

Fox Chase Cancer Center’s Dr. Richard J. Bleicher Appointed Vice Chair of the National Accreditation Program for Breast Centers and Chair of its Executive Committee

November 26th 2024

Richard J. Bleicher, MD, FACS, Chief of the Division of Breast Surgery and Clinical Director of the Breast Service Line at Fox Chase Cancer Center.